CIMT 2022 ANNUAL  MEETING

EpiVaxTx_CIMT22_Melanoma_27Apr22_24Wx32H.png

IMPACT OF CHECKPOINT INHIBITOR THERAPY ON SOMATIC MUTATIONS: TUMORS BECOME MORE STEALTH

Guilhem Richard, Ph.D.

2022 CIMT Annual Meeting

May 2022